Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOpus Genetics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.16 | -$0.12 | -$0.13 |
| Q2 2026 | 10 | -$0.20 | -$0.11 | -$0.16 |
| Q3 2026 | 11 | -$0.20 | -$0.08 | -$0.15 |
| Q4 2026 | 11 | -$0.22 | $0.22 | -$0.09 |
| Q1 2027 | 4 | -$0.37 | $0.01 | -$0.16 |
| Q2 2027 | 4 | -$0.39 | $0.01 | -$0.17 |
| Q3 2027 | 7 | -$0.39 | $0.01 | -$0.17 |
| Q4 2027 | 4 | -$0.34 | $0.01 | -$0.15 |
| Q1 2028 | 5 | -$0.02 | $0.46 | $0.20 |
| Q2 2028 | 6 | -$0.02 | $0.53 | $0.23 |
| Q3 2028 | 9 | -$0.02 | $0.62 | $0.27 |
| Q4 2028 | 5 | -$0.03 | $0.69 | $0.30 |
| Q1 2029 | 4 | -$0.04 | $0.96 | $0.41 |
| Q2 2029 | 6 | -$0.04 | $1.10 | $0.47 |
| Q3 2029 | 9 | -$0.05 | $1.28 | $0.55 |
| Q4 2029 | 4 | -$0.05 | $1.42 | $0.61 |
Opus Genetics Inc. Earnings Date And Information
Opus Genetics Inc. last posted its earnings results on Thursday, August 6th, 2026. The company reported $-0.14 earnings per share for the quarter, topping analysts' consensus estimates of $-0.15667 by $0.01667. The company had revenue of 755.00 K for the quarter and had revenue of 14.20 M for the year. Opus Genetics Inc. has generated $-1 earnings per share over the last year ($-0.8 diluted earnings per share) and currently has a price-to-earnings ratio of -3.19. Opus Genetics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Opus Genetics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2026 | Q2 2026 | -$0.16 | -$0.08 | 0.08 | $2.63 M | $755.00 K |
| 05/12/2026 | Q1 2026 | -$0.16 | -$0.75 | -0.59 | $2.93 M | $2.16 M |
| 03/12/2026 | Q4 2025 | N/A | -$0.19 | N/A | $3.14 M | $3.87 M |
| 11/12/2025 | Q3 2025 | -$0.14 | -$0.25 | -0.11 | $3.07 M | $3.08 M |
| 08/13/2025 | Q2 2025 | -$0.25 | -$0.12 | 0.13 | $4.05 M | $2.88 M |
| 05/15/2025 | Q1 2025 | -$0.34 | -$0.24 | 0.1 | $3.10 M | $4.37 M |
| 03/31/2025 | Q4 2024 | -$0.34 | -$1.11 | -0.77 | $3.40 M | $4.30 M |
| 11/12/2024 | Q3 2024 | -$0.24 | -$0.29 | -0.05 | $2.28 M | $3.87 M |
| 08/13/2024 | Q2 2024 | -$0.25 | -$0.30 | -0.05 | $2.45 M | $1.11 M |
| 05/10/2024 | Q1 2024 | -$0.11 | -$0.29 | -0.18 | $5.34 M | $1.71 M |
| 03/08/2024 | Q4 2023 | -$0.05 | -$0.22 | -0.17 | $5.36 M | $1.69 M |
| 11/13/2023 | Q3 2023 | -$0.22 | $0.26 | 0.48 | $3.03 M | $11.94 M |
| 06/30/2023 | Q2 2023 | N/A | -$0.24 | N/A | $2.43 M | $3.67 M |
| 03/31/2023 | Q1 2023 | N/A | -$0.28 | N/A | $2.95 M | $1.75 M |
| 12/31/2022 | Q4 2022 | N/A | $1.63 | N/A | $29.45 M | $39.85 M |
| 09/30/2022 | Q3 2022 | N/A | -$0.22 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.25 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.35 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$0.35 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$0.25 | N/A | N/A | $489.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Opus Genetics Inc. Earnings: FAQ's
In the previous quarter, Opus Genetics Inc. (:IRD) reported $-0.14 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.15667 by $0.01667.
The conference call for Opus Genetics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Opus Genetics Inc.'s latest earnings report can be read online.
Opus Genetics Inc. (:IRD) has a recorded annual revenue of $14.20 M.
Opus Genetics Inc. (:IRD) has a recorded net income of $-49,591,000.Opus Genetics Inc. has generated $-0.8 earnings per share over the last four quarters.
Opus Genetics Inc. (:IRD) has a price-to-earnings ratio of -3.19 and price/earnings-to-growth ratio is 0.08.